Outlook Therapeutics Inc
F:41O
Outlook Therapeutics Inc
F:41O
Price:
0.752
EUR
11.08%
Market Closed
Market Cap:
€33.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Outlook Therapeutics Inc
F:41O
|
US |
|
Research Solutions Inc
F:61I
|
US |
|
Aritzia Inc
TSX:ATZ
|
CA |
|
D
|
Dermapharm Holding SE
XHAM:DMP
|
DE |
|
G
|
GoDaddy Inc
F:38D
|
US |
|
R
|
Revvity Inc
XMUN:PKN
|
US |
|
H
|
Hormel Foods Corp
XMUN:HO7
|
US |
|
S
|
STINAG Stuttgart Invest AG
XMUN:STG
|
DE |
|
U
|
Uniper SE
F:UN01
|
DE |
|
Uniper SE
F:UN0
|
DE |
|
S
|
Shanghai Industrial Holdings Ltd
XMUN:SGI
|
HK |
Multiples-Based Value
The Multiples-Based Value for 
Outlook Therapeutics Inc (41O) under the Base Case is hidden
EUR.
Compared with the current market price of 0.752 EUR, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
41O Multiples-Based Value
LOCKED
